Intervention not reported
Adverse events: severe, grade > 2 (Duration of · stages I to III NSCLC patients treated with surgery or radiotherapy with curative intent
The intervention showed no clear difference in adverse events: severe, grade > 2 (Duration of (low certainty).
1 finding from 1 review
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or… 2021 · Cochrane Headline outcomes onlyRR 1.14 [0.92, 1.4]6 studies · 4546 participantsLow